IFN-c is known as a pro-inflammatory cytokine, but can also block inflammation in certain chronic diseases although the underlying mechanisms are poorly understood. We found that IFN-c rapidly induced Noxa expression and that extent of inflammation by repeated house dust mite exposure was enhanced in noxa À / À compared with noxa þ / þ mice. Noxa expression blocked transforming necrosis factor alpha (TNF-a)-induced nuclear translocation of nuclear factor kappalight-chain-enhancer of activated B cells (NF-jB) and the production of pro-inflammatory cytokines. Noxa did not affect TNF-a-induced IjBa phosphorylation but the degradation of 48-chain-ubiquitylated IjBa. The Cys25 of Noxa was crosslinked with Cys137 of phospho-HSP27 and both proteins were required for blocking the degradation of ubiquitylated IjBa. Because phospho-HSP27 is present in airway epithelial cells and not in fibroblasts or thymocytes, we generated transgenic mice that inducibly expressed Noxa in airway epithelia. These mice showed protection from allergen-induced inflammation and mucous cell metaplasia by blocking nuclear translocation of NF-jB. Further, we identified a Noxaderived peptide that prolonged degradation of 48-chain-ubiquitylated IjBa, blocked nuclear translocation of NF-jB, and reduced allergen-induced inflammation in mice. These results suggest that the anti-inflammatory role of the Noxa protein may be restricted to airway epithelial cells and the use of Noxa for therapy of chronic lung diseases may be associated with reduced side effects.
INTRODUCTION
Interferon gamma (IFN-g) is primarily produced by innate cells, including natural killer and natural killer T cells, noncytotoxic innate lymphoid cells, 1 and adaptive immune cells, including CD4 þ T helper (Th) 1 and CD8 þ cytotoxic T lymphocytes cells. 2 IFN-g activates macrophages to produce pro-inflammatory cytokines, 3 but can also counteract inflammatory and immunostimulatory pathways. 4 Transgenic mice engineered to express IFN-g in airway epithelial cells were found to present with increased inflammation and emphysema 5 but also with reduced eosinophilia and airway reactivity. 6 However, because airway epithelial cells do not express IFN-g, the findings in these transgenic mice may not be physiologically relevant.
For clinical applications, IFN-g has beneficial effects when administered as prophylactic treatment of lupus nephritis 7 and in cases of rheumatoid arthritis. 8 IFN-g signaling inhibits neutrophil accumulation in the lung 9 or suppresses neutrophil production in the bone marrow. 10 These anti-inflammatory responses are mediated by induction of cytokine decoy receptors, IL-1Ra and IL-18BP. 2 Further, IFN-g tempers the development of erythrocytes and eosinophilic granulocytes, 11 and inhibits Th2 cell function. 12 Because chronic inflammation promotes chronic lung diseases, 13 identifying the intracellular factors that mediate the anti-inflammatory action of IFN-g can be of great importance. Our previous studies have shown that IFN-g causes cell death in airway epithelial cells by activating STAT1, 14 inducing expression of the BH3-only protein, Bik, 15 and suppression of Bmf expression to induce autophagy. 16 Bik and Bmf are Bcl-2 family members that share only the Bcl-2 homology region 3 (BH3) such as Noxa, Puma, Bim, Bid, Bad, Bid, Bnip-3L, and Hrk. This group of proteins is believed to sense cell death signals that emanate from internal stresses, such as DNA damage 17 or CAP-independent translation 18 or from external stimuli, such as IFN-g 15 or other cytokines. 19 We found that in airway epithelial cells IFN-g dramatically induced the BH3-only protein, Noxa, but that Noxa did not induce cell death, yet inhibited inflammation in response to allergen. Noxa required the interaction with phosphorylated HSP27 via a covalent disulfide bond to suppress the nuclear translocation and activation of NF-kB by inhibiting degradation of ubiquitylated IkBa. Furthermore, inducible expression of Noxa in airway epithelia of adult mice suppressed allergeninduced inflammation in vivo. However, the cross-linking Cys25 was not necessary when the N-terminal peptide was used to block IkBa degradation and inflammation. Therefore, these studies identify the anti-inflammatory mediator of IFN-g to be Noxa cross-linked to the non-Bcl-2 protein, pHSP27 that renders N-terminal region of Noxa functional.
RESULTS

IFN-c rapidly induces Noxa expression to suppress inflammation
Noxa mRNA levels were dramatically induced by 25-50 ng ml À 1 IFN-g treatment over 24-48 h in primary human airway epithelial cells (HAECs) from non-diseased individuals (Supplementary Figure S1A online). Induction occurred within 1 h of IFN-g treatment both for Noxa mRNA (Figure 1a) , and protein levels (Figure 1b) , while Hrk, Bad, or Puma showed no change in expression (data not shown). This rapid induction by IFN-g was consistently observed in HAECs from 14 individuals ( Figure 1c ). As expected, Noxa protein and mRNA were undetectable in murine airway epithelial cells (MAECs) from noxa À / À mice but Noxa expression was increased by IFN-g in wild-type MAECs (Supplementary Figure S1B ). IFN-g failed to upregulate Noxa expression in MAECs from STAT1 À / À mice (Supplementary Figure S1B ). However, unlike the DNA damage-induced Noxa expression, 20 IFN-g-induced Noxa expression was independent of p53 (Supplementary Figure S1C ).
Noxa deficiency causes increased inflammation
While Noxa mRNA and protein levels were induced robustly by IFN-g, noxa þ / þ and noxa À / À airway cells were both susceptible to IFN-g-induced cell death (Supplementary Figure S1D ). However, we observed that noxa À / À compared with noxa þ / þ mice developed increased inflammation following intranasal instillation with house dust mite allergen for 5 consecutive days. The numbers of total cells ( Figure 1d ) eosinophils and macrophages, but not neutrophils and lymphocytes (Figure 1e ), recovered by bronchoalveolar lavage, were significantly higher in noxa À / À compared with noxa þ / þ mice. In addition, when sensitized with ovalbumin injection on days 1 and 7 and challenged with ovalbumin aerosols for 5 days, mucous cell numbers were higher (Supplementary Figure S2A ) and inflammatory cells were more evident in noxa À / À compared with noxa þ / þ mice (Supplementary Figure S2B) . These observations suggested that Noxa may play a role in blocking allergen-induced inflammation, but not in the cell death process of hyperplastic airway epithelial cells. Previous studies have shown that Noxa expression sensitizes cells to apoptosis. 21 To determine whether Noxa sensitizes airway epithelial cells, we first treated HAECs with increasing H 2 O 2 concentrations and found that 45 mM affects cell viability slightly (Supplementary Figure S2C ). However, when combined with increasing multiplicity of infection of Ad-Noxa, cell viability was progressively reduced compared to the Ad-GFP controls (Supplementary Figure S2D ).
Because expression of many pro-inflammatory genes are regulated by NF-kB including IL-8, 22 we investigated whether Noxa suppresses the synthesis of inflammatory chemokines. The TNFa-induced IL-8 secretion from human airway epithelial cells was significantly reduced when Noxa was expressed using an adenoviral expression vector (Ad-Noxa) compared to Ad-GFP-infected controls (Figure 2a ). The possible role of Noxa in affecting NF-kB activation was tested using the A549-NF-kB-luc cells that are stably transfected with a luciferase reporter gene driven by a promoter containing several NF-kB response elements. As expected, TNFa-induced luciferase activity was inhibited when Noxa was expressed in a dose-dependent manner ( Figure 2b) ; no cell death was detected by Ad-Noxa even at a multiplicity of infection of 300 (data not shown). Further, suppression of Noxa expression using shRNA enhanced IFN-g-induced NF-kB activity in cells treated with TNFa for 30 min (Figure 2c ). Further, merely expressing Noxa or expressing Noxa in the presence of IFN-g treatment showed a similar reduction in A549-NF-kB-luc cells, showing that IFN-g had no further impact on Noxa-mediated suppression of NF-kB activity (Supplementary Figure S2F ). Together, these findings suggest that the anti-inflammatory effect of IFN-g is mediated by Noxa.
We next analyzed the effects of IFN-g or Noxa on TNFainduced change in sub-cellular localization of NF-kB. While NF-kB was localized to the nucleus 30 min after TNFa treatment, it remained localized to the cytosol in cells that were pretreated with IFN-g for 24 h (Figure 2d) . Similarly, direct expression of Noxa using adenoviral vectors suppressed TNFa-induced nuclear translocation of NF-kB as shown by immunofluorescence (Figure 2e ). In addition, IFN-g was delayed in suppressing nuclear translocation of NF-kB in noxa À / À MAECs (Figure 2f ), confirming that IFN-g requires Noxa to delay NF-kB activation. These findings were further confirmed by immunoblotting of nuclear and cytoplasmic extracts that showed nuclear NF-kB being significantly reduced in cells pretreated with IFN-g compared to non-treated controls (Supplementary Figure S2F ).
Noxa blocks the degradation of ubiquitylated IjB-a
In non-stimulated cells, the inhibitory IkBa protein sequesters NF-kB to the cytoplasm and inflammatory stimuli activate IKKa and IKKb to phosphorylate IkBa, which leads to its ubiquitylation and proteasomal degradation, releasing NF-kB to translocate to the nucleus. 23, 24 Over 0, 15, and 30 min of TNFa treatment, IkBa levels were reduced in the cytosolic extracts of noxa À / À but not noxa þ / þ MAECs (Supplementary Figure S2G ), suggesting that Noxa stabilizes IkBa. TNFa-induced nuclear translocation of NF-kB was also significantly reduced following overexpression of Noxa using Ad-Noxa compared to cells infected with Ad-GFP ( Figure 2g ), suggesting that Noxa expression is sufficient to stabilize IkBa. Interestingly, after 10 min of TNF-a treatment the levels of phosphorylated IkBa were similar in HAECs infected with Ad-Noxa and Ad-GFP as control ( Figure 2h ). Lysine-48 (K48)-linked polyubiquitin chains are well established as the canonical signal for proteasomal degradation. 25 Interestingly, the levels of IkBa with homotypic K48-linked ubiquitin chains were increased in HAECs infected with Ad-Noxa and expressed Noxa compared with Ad-GFP-infected controls (Figure 2i ). This finding suggests that Noxa blocks the proteasomal degradation of IkBa that is already destined for degradation. 
Noxa is cross-linked to phosphorylated HSP27
Because Noxa is known to inactivate Mcl-1 and thereby sensitize cells to apoptotic death, 26, 27 we tested the hypothesis that Noxa may interact with other protein(s) to gain anti-inflammatory properties. Noxa antibodies consistently detected a cross-reacting protein of approximately 32 kDa in size only in IFN-g-treated HAECs (Figure 3a) . Peptide mass fingerprint analysis of the cross-reacting the 32 kDa band excised following immunoprecipitation repeatedly revealed a high score for HSP27 ( Supplementary Table S1 ). This observation was confirmed by immunoblotting of anti-Noxa immunoprecipitated proteins with an antibody to HSP27 phosphorylated at Ser 82 (Figure 3b ). Interestingly, Mcl-1 and Bcl-x L , proteins known to interact with Noxa, 27 were not detected in the immunoprecipitates (Figure 3b ). Immunoprecipitation with p-S 82 HSP27 antibodies confirmed that Noxa forms a complex with phosphorylated HSP27 (pHSP27) (Figure 3c ). The interaction between Noxa and pHSP27 was further verified by pull-down assays from extracts prepared from AALEB cells using recombinant, purified GST-Noxa protein and detecting pHSP27 protein by western blot analysis (Figure 3d ). Blocking the phosphorylation of expressed HSP27 using the p38MAPK inhibitor, SB203580, reduced the levels of immunoprecipitated pHSP27-Noxa complex (Figure 3e ), further supporting that pHSP27 rather than total HSP27 needs to be present to form the Noxa/pHSP27 interaction. Interestingly, merely overexpressing Noxa by infecting cells with Ad-Noxa in the absence of IFN-g also resulted in the appearance of the 32 kDa Noxa-pHSP27 complex (Supplementary Figure S3A ), suggesting that IFN-g was not inducing a cross-linking enzyme to facilitate this complex formation. The idea that Noxa and p-HSP27 are linked by disulfide bond(s) was confirmed by the absence of the p-HSP27-GST-Noxa complex in pull-down products from cell extracts treated with the reducing reagent, DTT that cleaves disulfide bonds (Supplementary Figure S3B) .
To identify the amino acids within Noxa that are responsible for the Noxa-HSP27 complex, we generated various mutant GST-Noxa proteins that were tested in pull-down assays. Deletions of 10 amino acids from the N-terminus (Noxa-D5 0 ) or 14 amino acids from the C-terminus (Noxa-D3 0 ) abrogated the interactions of Noxa and pHSP27 (Supplementary Figure S3C ). Because 293T cells express no detectable levels of endogenous HSP27, these cells were co-transfected with an HSP27-expression vector along with wild-type Noxa, Noxa-2CS, and Noxa-3KR. Mutations of cysteines 25 and 51 to serines (Noxa-2CS) also disrupted the interactions while mutation of lysines 35, 38 , and 41 to argnines (Noxa-3KR) did not (Figure 3f ).
Further mutagenesis experiments demonstrated that only Cys 25 residue was essential for the formation of Noxa-phospho-HSP27 complex (Figure 3f ) confirming the hypothesis that Noxa and HSP27 are linked by an intermolecular disulfide bond.
Because HSP27 contains only one cysteine residue at position 137, the role of this residue was investigated by comparing wild-type and C137A mutant HSP27 constructs expressed in 293T cells that were treated with IFN-g to induce Noxa. Although expression levels of pHSP27 were equal in cells transfected with either construct, immunoprecipitation with Noxa antibodies showed that the formation of Noxa-pHSP27 was impaired in cells transfected with the C137A mutant and was accompanied by the loss of interactions with IkBa/NF-kB complex (Figure 3g) . These studies demonstrated that an intermolecular disulfide bond between Cys 25 in Noxa and Cys 137 in HSP27 cross-links Noxa to pHSP27 to allow the formation of a complex with IkBa and NF-kB.
HSP27 is essential for Noxa-IjBa-NF-jB interaction Suppression of HSP27 in AALEB cells by stably expressing shHSP27 did not affect IFN-g-induced Noxa expression ( Supplementary Figure S3D) . These cells were used to investigate the contribution of pHSP27 in blocking nuclear translocation of NF-kB. As shown by immunofluorescence staining IFN-g blocked nuclear translocation of NF-kB in shCtrl but not in shHSP27 cells (Figure 3h ). In addition, when Noxa or HSP27 expression in AALEB cells was reduced using shNoxa or shHSP27, IFN-g no longer suppressed secretion of IL-8 (Supplementary Figure S3E ) or IL-6 (Supplementary Figure  S3F) . Therefore, we proceeded to determine whether the interaction of Noxa with IkBa/NF-kB would be disrupted by reducing HSP27 levels. Although NF-kB and IkBa were equally expressed in shCtrl and shHSP27 cells, the interactions between Noxa and NF-kB or IkBa were abolished in shHSP27 cells (Figure 3i) . Immunoprecipitation with NF-kB (p65) antibodies from shHSP27 cell extracts showed that the interaction of NF-kB with IkBa was essentially completely disrupted when cells were treated with TNFa, suggesting that IkBa degradation occurred faster when HSP27 was suppressed (Figure 3i) . Further, the NF-kB-Noxa interaction was disrupted in shHSP27 cells but not in shCtrl cells (Figure 3i) and TNFa-induced degradation of IkBa was enhanced in shHSP27 compared with shCtrl cells (Figure 3j ), suggesting that pHSP27 also is crucial in stabilizing IkBa. Therefore, Noxa requires the presence of pHSP27 to interact with the IkBa/NF-kB complex and the cross-linking of pHSP27 and Noxa appears to play a critical role in stabilizing IkBa.
Inducible expression of Noxa in AECs protects from allergic inflammation and mucous cell hyperplasia
Constitutive expression of HSP27 has been detected in the lungs of mice 28 but the presence of phosphorylated HSP27 in various tissues and cell types have not been studied. Because the cross-linking of Noxa to pHSP27 may be specific to airway epithelia, we compared pHSP27 levels in various tissues and cell types. Phospho-HSP27 was detected in MAECs and in lung tissues but not in murine embryo fibroblasts, thymus, and liver tissues (Figure 4a) . To investigate the anti-inflammatory and possibly the therapeutic role of Noxa expression in airway epithelial cells in vivo, we generated a conditional inducible transgenic (Noxa Ind ) mouse using the tetO-CCSP promoter system. Immunofluorescence analyses showed induced levels of Noxa in the bronchial epithelial cells of three founder Noxa Ind mouse lines compared with wild-type littermates (Figure 4b) . These mice expressed Noxa mRNA and protein in the lung tissues 24 h post doxycycline (dox)-diet ( Figure 4c) . These transgenic mice and littermate controls were instilled with house dust mite (HDM) extract for 5 consecutive days, given the dox-diet on days 6 and 7, and killed on day 8. The number of total inflammatory cells in the bronchoalveolar lavage fluid was reduced in Noxa Ind mice compared to littermate controls and these reduced numbers were due to reduced bronchoalveolar lavage eosinophils and lymphocytes (Figure 4d) . The no dox, no HDM, dox-fed but not HDM mice controls showed only macrophages and no inflammation (data not shown). Transgenic expression of Noxa also resulted in a threefold reduced number of mucous cells per mm basal lamina compared with littermate controls (Figure 4e ). Immunofluorescence analysis showed that expressed Noxa was co-localized with NF-kB in the cytosol resulting in the lower percentage of airway epithelial cells with nuclear NF-kB in Noxa Ind mice (Figure 4f ). Further, pHSP27 was co-localized with induced Noxa (Supplementary Figure S4A ) and NF-kB (Supplementary Figure S4B) in airway epithelial cells of Noxa Ind mice.
The N-terminal Noxa peptide stabilizes IjBa and is antiinflammatory
We further tested whether specific regions of the Noxa protein may act as anti-inflammatory by using Noxa-derived peptides. Based on our findings that Cys25 constitutes the cross-linking amino acid, and because the human and murine Noxa proteins share a high homology, except that the murine Noxa contains the duplicate sequence ( Supplementary Figure S5A) , we selected four regions that are 15 amino acids in length and span the following functional regions of the human Noxa protein. Peptide NoxaA represents the N-terminus, NoxaB contains Cys25, NoxaC comprises the BH3 domain, and NoxaD represents the C-terminal end of the protein (Supplementary Figure S5B ). To facilitate uptake into cells, the peptides were synthesized with the HIV-derived TAT sequence on their N-termini. When A549 cells were treated with 10 ng ml À 1 TNFa, NF-kB-induced luciferase activity was reduced by NoxaA and NoxaD peptides but not by NoxaB or NoxaC (Figure 5a ). However, when nuclear localization of NF-kB was investigated in TNFa-treated MAECs by immunofluorescence, only NoxaA but not NoxaD or the control TAT peptide affected nuclear localization (Figure 5b) .
To examine the anti-inflammatory effect in vivo, noxa À / À mice were intranasally instilled with 50 mg house dust mite allergen for 5 consecutive days and then instilled with NoxaA peptide on days 6 and 7. The number of inflammatory cells in the bronchoalveolar lavage fluid mice was significantly reduced by NoxaA ( Figure 5c ) and this reduction was due to reduced numbers of eosinophils (Figure 5d ). The number of neutrophils, macrophages, and lymphocytes were not affected (data not shown). After 10 min of TNF-a treatment the levels of IkBa with homotypic K48-linked ubiquitin chains were increased in AALEB cells treated with NoxaA compared to Ctrl peptide (Figure 5e ).
DISCUSSION
The present studies show that IFN-g through STAT1 activation rapidly induces Noxa which is cross-linked with a non-Bcl-2 family member, pHSP27, and suppresses the canonical NF-kB signaling pathway. Therefore, these findings define the mediator by which IFN-g acts as anti-inflammatory and are the first to show that a Bcl-2 family member could inhibit inflammation by reducing NF-kB activation.
Members of the extrinsic apoptotic machinery, including the TNFR1 interactors, TRADD, FADD, and RIPK1, 29 are known to be required for optimal NF-kB activation. The present study adds a new paradigm by showing that a member of the intrinsic apoptotic machinery affects the immune response by directly blocking NF-kB activation. It is well-established that proteins of the Bcl-2 family interact with each other to control the permeabilization of the mitochondrial outer membrane and thereby regulate apoptosis. However, only a limited number of studies have explored their interaction with non-Bcl-2 family members and their roles in cellular processes other than those related to cell death. For example, Bad effects insulin secretion and metabolism 30 and BID, contrary to Noxa, by interacting with NOD1, NOD2, and the IkB kinase (IKK) complex facilitates NF-kB activation. 31 Noxa is induced rapidly also by hypoxia via hypoxiainducible factor (HIF)-1a, 32 by DNA damage, 17 by ER stress inducing agents. 33 Furthermore, anticancer agents, including the proteasome inhibitor, bortezomib, or ubiquitylation of Mcl-1, induce Noxa expression. 34 All these studies used fibroblasts, chronic lymphocytic leukemia, melanoma, neuroblastoma, osteosarcoma, and lung cancer cells and investigated expressed Noxa interacting with the anti-apoptotic Mcl-1 to regulate cell death by affecting Mcl-1 degradation. 25, 35 However, although Mcl-1 was present in airway epithelial cells, the presence of pHSP27 caused the IFN-g-induced Noxa to prefer the cross-linking with pHSP27 and not Mcl-1. Ser 13 phosphorylation alters Noxa structure and blocks the interaction site with Mcl-1. 36 Whether pHSP27 phosphorylates Noxa or just forces the N-terminal region to be exposed for interaction with IkBa is unclear. While the phosphorylation and ubiquitylation process remained unaffected, Noxa delayed the degradation of IkBa after it was already tagged by the K48 ubiquitin chain. Small molecules, called ubistatins, block the binding of ubiquitylated substrates to the proteasome by targeting the ubiquitinubiquitin interface of K48-linked chains. 34 Whether the N-terminus of Noxa interacts with the IkBa-specific proteins or the ubiquitin-ubiquitin interface or blocks the interaction of ubiquitylated IkBa to the 19S proteasome before being shuttled for degradation needs further investigation.
The airway epithelium is constantly exposed to the elements of the outer world and therefore has to continuously regulate inflammation. We show that Noxa is rapidly induced within hours and this rapid response allows the fine-tuning or unnecessary enhancement of inflammation. Given that Noxa expression in airway epithelium causes a significant difference in inflammation reveals that this protein contributes to the antiinflammatory protective role of the airway epithelium. Because many pathways are not necessarily associated with inflammation, including autophagy, regulators of ROS also play a role in regulating inflammation; the induction of Noxa may be one of many mechanisms by which the airway epithelium dampens inflammation. Noxa expression can either sensitize airway cells when cells are damaged or inhibit inflammation. The present studies also suggest that the underlying mechanisms of Noxainduced cell death in airway epithelial cells need further investigation, because Noxa-induced cell death may not only depend on enhanced degradation of Mcl-1 but also on blocking NF-kB activation that directly regulates expression of the antiapoptotic Bcl-2.
Both the whole Noxa protein when cross-linked with pHSP27 and the peptide comprising the N-terminal region without the cross-linking Cys25 equally delayed the proteasomal degradation of ubiquitylated IkBa. Therefore, the role of pHSP27 is likely to expose the N-terminal region of Noxa to form a complex with IkBa and NF-kB. HSP27 has vastly different functions, including reducing growth or proliferation and increasing differentiation, and protecting against apoptosis. 35 This diverse function of HSP27 may depend on its ability as a chaperone protein to interact with other proteins that are present in various cell types or conditions. Further, HSP27 can be phosphorylated at three serine residues, resulting in the redistribution of the large oligomer into smaller tetrameric units, and its dephosphorylation favors the formation of large oligomers, the dimer of HSP27 being the building block for multimeric complexes that can be up to 1000 kDa. 37 It is possible that depending on the phosphorylation state, HSP27 interacts with different proteins to ultimately mediate different outcomes. For example, in prostate cancer cells, HSP27-eIF4E interaction defines the chaperoning role of HSP27 to decrease eIF4E ubiquitylation and proteasomal degradation to protect the protein synthesis initiation process and survival. 38 Similarly, hic-5 interacts with HSP27 and blocks the anti-apoptotic role of HSP27. 39 Our finding that pHSP27 has an anti-inflammatory role is consistent with the report that HSP27 deficiency in mice augments neutrophil infiltration in wounds. 40 In other studies, HSP27 can enhance NF-kB activity by interacting with IKK 41 or by interacting with polyubiquitin chains. 42 However, these studies focused on analyzing the presence or absence of HSP27 and did not investigate the phosphorylation state of HSP27. Our studies demonstrate a novel observation that Noxa expression being highly induced in airway epithelial cells may define the anti-inflammatory function of pHSP27.
The finding that pHSP27 is primarily detected in lung tissues or airway epithelial cells would suggest that the antiinflammatory role of Noxa is restricted to AECs. Consistent with this hypothesis, inducible Noxa expression in airway epithelial cells of transgenic mice was effective in suppressing inflammation. Delivering the NoxaA peptide directly to the airways may be a useful tool to temper inflammatory responses by prolonging the half-life of IkBa. Therefore, developing therapeutic vectors that deliver Noxa proteins or peptides to the airway epithelium or molecules that specifically induce Noxa expression in airway cells would represent novel anti-inflammatory tools to control chronic inflammation. Noxa as a treatment may be effective particularly in diseases that are associated with high levels of pHSP27, including COPD, 43 asthma, 44 and cancer. 45 IFN-g has been used to treat chronic inflammatory diseases, but as a pleiotropic cytokine, it has many effects. By identifying Noxa as the protein that mediates the antiinflammatory role of IFN-g, this study may have uncovered a means to harness the anti-inflammatory benefits of IFN-g and minimize the other effects of IFN-g. This would place Noxa in a unique position among anti-inflammatory therapeutic agents, especially when prolonged treatments are expected in chronic inflammatory diseases, such as asthma and COPD.
METHODS
Animals. All mouse studies were performed at the Lovelace Respiratory Research Institute (LRRI), a facility approved by the Association for the Assessment and Accreditation for Laboratory Animal Care International using protocols, pre-approved by the Institutional Animal Care and Use Committee (IACUC), and the Environmental Safety and Health department (ES&H). Noxa À / À on C57Bl/6 background mice were provided by Dr A. Strasser (Walter and Eliza Hall Institute, Melbourne, Australia) and p53 -/ þ breeders were purchased from The Jackson Laboratory (Ben Harbor, ME) and were bred at LRRI. 17 Mice were housed in isolated cages under specific pathogen-free conditions for the described studies.
The conditional and airway-specific overexpression of Noxa was achieved by mating two lines of transgenic mice, the CCSP-reverse tetracyclineresponsive transactivator (rtTA) mice, bearing the rtTA under the control of the CCSP gene promoter, 46 and the tetracycline operator (TetO) 7 -Noxa mice, containing TetO and minimal cytomegalovirus promoter and the Noxa transgene. (TetO) 7 -Noxa mice were generated at the MD Anderson Genetically Engineered Mouse Facility following standard methods and Institutional Animal Care and Use Committee-approved protocols and bred with CCSP-rtTA mice at LRRI. The transgene plasmid was cut with HindIII and NheI, and murine Noxa cDNA was separated from the TG-1 vector. Purified murine Noxa cDNA was injected into the pronuclei of zygotes collected from superovulated (C57BL/6) female mice, and injected zygotes were transferred to pseudopregnant ICR recipient females. Founder animals were identified by polymerase chain reaction amplification of 2.5 ml of tail DNA segments digested overnight in NaOH at 55 1C. Oligonucleotides were as follows: a, 5'-AGGGATC-CAT GTGTATTGTA TGTGGGCTC TAACCTGGC-3'; b, 5'-TGCAGCTAGG TGAGCGTCCA CAGGACCCTG AGTGGT-3'. To conditionally express murine Noxa in the lung, transgenic mice were fed with doxycycline-containing diet. Founder animals (C57Bl/ 6J) were bred to C57Bl/6J Â C57Bl/6J animals to evaluate germline transmission. Six lines that transmitted the Noxa sequence were analyzed by quantitative polymerase chain reaction (q-PCR) for expression of Noxa in lung and tracheal tissue. On the basis of these results, three murine lines with expression of Noxa in the airway epithelia were chosen for colony expansion and line 2 was maintained by breeding with wild-type C57Bl/6 mice and using the wild-type littermates as controls for each experiment.
Exposures. At 6-10 weeks of age, mice were entered into the experimental protocols. Mice were instilled with HDM extracts for 5 consecutive days and lung tissues were analyzed 24 or 72 h post the last challenge. HDM (Greer Laboratories, Lenoir, NC) was from Dermatophagoides Pteronyssinus (lot #248041), as 21.5 mg protein per 103.3 mg dry weight in a freeze-dried form was resuspended in sterile phosphate buffered saline for a final concentration of 1 mg ml À 1 and stored in frozen aliquots at À 20 1C. Sensitization and exposure of mice to ovalbumin was as described previously. 47 Bronchoalveolar lavage and preparation of lung tissues for histopathological examination and staining with Alcian blue/hematoxylin and eosin was as described. 47 Cells. Primary HAECs (Cambrex Bio Science, Walkersville MD, Inc.), MAECs, AALEB cells, A549 cells stably transfected with multiple copies of the NF-kB response element driving a luciferase reporter construct (A549-NF-kB-luc cell line) (Panomics, Inc., Redwood City, CA.), and 293T cells were cultured as described previously. 14 AALEB cells are immortalized HAECs that have been well characterized. 48 Cells were maintained in bronchial epithelial growth medium BEGM (Lonza, Walkersville, MD) supplemented with growth factors (BEGM Singlequots, Lonza) as described previously. 14 Adenoviral expression vectors for Noxa were provided by Dr G. Shore (McGill University, Montreal, Canada), and cells were infected as previously described. 49 The A549-NF-kB-luc cell line was purchased from Panomics, Inc., CA and grown in Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen, Waltham, MA) supplemented with 10% fetal bovine serum, 1 mM sodium pyruvate (Invitrogen), penicillin/streptomycin (Invitrogen) and hygromycin. The 293T cells were cultured in DMEM with 10% fetal bovine serum. Transfections were carried out with the TransIT-2020 Transfection Reagent (Mirus Bio, Madison, WI) according to the manufacturer's protocol. Cell viability was determined by trypan blue exclusion.
MAECs were isolated essentially as described previously 50 by incubation in pronase solution (DMEM, 1.4 mg ml À 1 pronase and 0.1 mg ml À 1 DNase) overnight at 4 1C to dissociate airway epithelial cells from the basal lamina. Cells were collected by gently rocking trachea in DMEM/Ham H12 media (Invitrogen) followed by centrifugation at 400 g for 10 min at 4 1C. MAECs were grown in media described previously. 51 Generation of expression constructs. The GST-tagged recombinant proteins of the full length Noxa (pGEX-Noxa), 5 0 or 3 0 truncated versions (pGEX-NoxaD5 0 or pGEX-NoxaD3 0 ), C25/51S mutant (pGEX-Noxa-2CS), and C-terminal K35/38/41R mutant (pGEX-Noxa-3KR) were expressed in pGEX-5X-1 Gene Fusion System (GE Health). The constructs were generated by amplifying the desired coding regions with appropriate mutations using PCR and inserting the products into the BamHI and EcoRI sites of pGEX-5X1 vector. The primers for generating NOXA full-length and truncated constructs Gene Expression kit (Life Technologies, Waltham, MA). The mRNA levels of KC from MAECs were quantified using High Capacity RNAto-cDNA Kit (Life Technologies) and QuantiTect SYBR Green PCR Kit (Qiagen, Germantown, MD ).
Statistical analysis. Grouped results from at least three different experiments were expressed as means ± s.e.m. Results (grouped by time point and treatment) were analyzed using two-way analysis of variance. In the event that significant main effects were detected (Po0.05), Fisher's least significant difference test was used to differentiate between groups. A P-value of 0.05 was considered to indicate statistical significance. Data were analyzed using statistical analysis software (Statistical Analysis Software Institute).
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